Edwards Lifesciences Corporation Payments to Acquire Held-to-maturity Securities
Edwards Lifesciences Corporation (EW) reported Payments to Acquire Held-to-maturity Securities of $18.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2026-08-04
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for the quarter ending 2026-06-30 was $5.80M, a 3.33% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for the quarter ending 2026-03-31 was $12.50M, a 2.34% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for the quarter ending 2025-12-31 was $100.00K, a 98.96% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for the quarter ending 2025-09-30 was $24.40M, a 9.91% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for fiscal 2025 was $43.30M, a 5.66% decline from fiscal 2024.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for fiscal 2024 was $45.90M, a 30.87% decline from fiscal 2023.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for fiscal 2023 was $66.40M, a 81.22% decline from fiscal 2022.
- Edwards Lifesciences Corporation payments to acquire held-to-maturity securities for fiscal 2022 was $353.50M, a 41.40% increase from fiscal 2021.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $18.30M 10-Q · filed 2026-08-04 | $18.40M derived: sum of 3 quarters · filed 2026-08-04 | $42.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $12.50M 10-Q · filed 2026-05-06 | $12.60M derived: sum of 2 quarters · filed 2026-05-06 | $37.00M derived: sum of 3 quarters · filed 2026-05-06 | $43.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $24.50M derived: sum of 2 quarters · filed 2026-02-25 | $30.50M derived: sum of 3 quarters · filed 2026-08-04 | $43.30M 10-K · filed 2026-02-25 |
| 2025-09-30 | $24.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $30.40M derived: sum of 2 quarters · filed 2026-08-04 | $43.20M 10-Q · filed 2025-11-05 | $52.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $18.80M 10-Q · filed 2026-08-04 | $28.40M derived: sum of 3 quarters · filed 2026-08-04 | $50.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $12.80M 10-Q · filed 2026-05-06 | $22.40M derived: sum of 2 quarters · filed 2026-05-06 | $44.60M derived: sum of 3 quarters · filed 2026-05-06 | $57.90M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $31.80M derived: sum of 2 quarters · filed 2026-02-25 | $45.10M derived: sum of 3 quarters · filed 2026-02-25 | $45.90M 10-K · filed 2026-02-25 |
| 2024-09-30 | $22.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $35.50M derived: sum of 2 quarters · filed 2025-11-05 | $36.30M 10-Q · filed 2025-11-05 | $79.20M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $13.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $14.10M 10-Q · filed 2025-08-06 | $57.00M derived: sum of 3 quarters · filed 2026-02-25 | $65.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $800.00K 10-Q · filed 2025-05-06 | $43.70M derived: sum of 2 quarters · filed 2026-02-25 | $51.70M derived: sum of 3 quarters · filed 2026-02-25 | $54.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $42.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $50.90M derived: sum of 2 quarters · filed 2026-02-25 | $53.90M derived: sum of 3 quarters · filed 2026-02-25 | $66.40M 10-K · filed 2026-02-25 |
| 2023-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $11.00M derived: sum of 2 quarters · filed 2024-11-06 | $23.50M 10-Q · filed 2024-11-06 | $91.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $15.50M 10-Q · filed 2024-07-31 | $83.50M derived: sum of 3 quarters · filed 2025-02-28 | $188.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $12.50M 10-Q · filed 2024-04-29 | $80.50M derived: sum of 2 quarters · filed 2025-02-28 | $185.30M derived: sum of 3 quarters · filed 2025-02-28 | $238.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $172.80M derived: sum of 2 quarters · filed 2025-02-28 | $225.50M derived: sum of 3 quarters · filed 2025-02-28 | $353.50M 10-K · filed 2025-02-28 |
| 2022-09-30 | $104.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $157.50M derived: sum of 2 quarters · filed 2023-10-27 | $285.50M 10-Q · filed 2023-10-27 | $432.50M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-06-30 | $52.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $180.70M 10-Q · filed 2023-07-28 | $327.70M derived: sum of 3 quarters · filed 2024-02-12 | $395.70M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-03-31 | $128.00M 10-Q · filed 2023-04-28 | $275.00M derived: sum of 2 quarters · filed 2024-02-12 | $343.00M derived: sum of 3 quarters · filed 2024-02-12 | $378.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2021-12-31 | $147.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $215.00M derived: sum of 2 quarters · filed 2024-02-12 | $250.00M derived: sum of 3 quarters · filed 2024-02-12 | $250.00M 10-K · filed 2024-02-12 |
| 2021-09-30 | $68.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $103.00M derived: sum of 2 quarters · filed 2022-10-28 | $103.00M 10-Q · filed 2022-10-28 | $153.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $35.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $35.00M 10-Q · filed 2022-07-29 | $85.00M derived: sum of 3 quarters · filed 2023-02-13 | $85.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-28 | $50.00M derived: sum of 2 quarters · filed 2023-02-13 | $50.00M derived: sum of 3 quarters · filed 2023-02-13 | $50.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $50.00M derived: sum of 2 quarters · filed 2023-02-13 | $50.00M derived: sum of 3 quarters · filed 2023-02-13 | $162.00M 10-K · filed 2023-02-13 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 derived: sum of 2 quarters · filed 2021-10-29 | $112.00M 10-Q · filed 2021-10-29 | $212.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $112.00M 10-Q · filed 2021-07-30 | $212.20M derived: sum of 3 quarters · filed 2022-02-14 | $212.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $112.00M 10-Q · filed 2021-04-28 | $212.20M derived: sum of 2 quarters · filed 2022-02-14 | $212.20M derived: sum of 3 quarters · filed 2022-02-14 | $212.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $100.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $100.20M derived: sum of 2 quarters · filed 2022-02-14 | $100.20M derived: sum of 3 quarters · filed 2022-02-14 | $130.20M 10-K · filed 2022-02-14 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $0.00 derived: sum of 2 quarters · filed 2020-10-26 | $30.00M 10-Q · filed 2020-10-26 | $50.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $30.00M 10-Q · filed 2020-07-27 | $50.00M derived: sum of 3 quarters · filed 2021-02-12 | $240.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $30.00M 10-Q · filed 2020-04-28 | $50.00M derived: sum of 2 quarters · filed 2021-02-12 | $240.00M derived: sum of 3 quarters · filed 2021-02-12 | $240.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $210.00M derived: sum of 2 quarters · filed 2021-02-12 | $210.00M derived: sum of 3 quarters · filed 2021-02-12 | $210.00M 10-K · filed 2021-02-12 |
| 2018-09-30 | $190.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $190.00M derived: sum of 2 quarters · filed 2019-10-25 | $190.00M 10-Q · filed 2019-10-25 | $278.00M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $0.00 10-Q · filed 2019-07-26 | $88.00M derived: sum of 3 quarters · filed 2020-02-14 | $299.30M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 | $88.00M derived: sum of 2 quarters · filed 2020-02-14 | $299.30M derived: sum of 3 quarters · filed 2020-02-14 | $804.90M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $299.30M derived: sum of 2 quarters · filed 2020-02-14 | $804.90M derived: sum of 3 quarters · filed 2020-02-14 | $804.90M 10-K · filed 2020-02-14 |
| 2017-09-30 | $211.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $716.90M derived: sum of 2 quarters · filed 2018-10-26 | $716.90M 10-Q · filed 2018-10-26 | $732.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $505.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $505.60M 10-Q · filed 2018-07-27 | $520.70M derived: sum of 3 quarters · filed 2019-02-15 | $645.80M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $0.00 10-Q · filed 2017-04-28 | $15.10M derived: sum of 2 quarters · filed 2019-02-15 | $140.20M derived: sum of 3 quarters · filed 2019-02-15 | $442.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $140.20M derived: sum of 2 quarters · filed 2019-02-15 | $442.20M derived: sum of 3 quarters · filed 2019-02-15 | $594.70M 10-K · filed 2019-02-15 |
| 2016-09-30 | $125.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $427.10M derived: sum of 2 quarters · filed 2017-10-27 | $579.60M 10-Q · filed 2017-10-27 | $604.60M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $302.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $454.50M 10-Q · filed 2017-07-28 | $479.50M derived: sum of 3 quarters · filed 2018-02-16 | $829.60M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $152.50M 10-Q · filed 2017-04-28 | $177.50M derived: sum of 2 quarters · filed 2018-02-16 | $527.60M derived: sum of 3 quarters · filed 2018-02-16 | $659.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $375.10M derived: sum of 2 quarters · filed 2018-02-16 | $506.50M derived: sum of 3 quarters · filed 2018-02-16 | $928.50M 10-K · filed 2018-02-16 |
| 2015-09-30 | $350.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $481.50M derived: sum of 2 quarters · filed 2016-10-28 | $903.50M 10-Q · filed 2016-10-28 | $1.26B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $131.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $553.40M 10-Q · filed 2016-07-29 | $909.80M derived: sum of 3 quarters · filed 2017-02-17 | $1.36B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $422.00M 10-Q · filed 2016-04-29 | $778.40M derived: sum of 2 quarters · filed 2017-02-17 | $1.23B derived: sum of 3 quarters · filed 2017-02-17 | $1.99B derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $356.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $809.90M derived: sum of 2 quarters · filed 2017-02-17 | $1.56B derived: sum of 3 quarters · filed 2017-02-17 | $1.96B 10-K · filed 2017-02-17 |
| 2014-09-30 | $453.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $1.21B derived: sum of 2 quarters · filed 2015-10-29 | $1.60B 10-Q · filed 2015-10-29 | $2.05B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $754.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $1.15B 10-Q · filed 2015-07-29 | $1.60B derived: sum of 3 quarters · filed 2016-02-19 | $1.75B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $391.80M 10-Q · filed 2015-04-29 | $841.10M derived: sum of 2 quarters · filed 2016-02-19 | $993.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.12B derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $449.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $601.20M derived: sum of 2 quarters · filed 2016-02-19 | $730.50M derived: sum of 3 quarters · filed 2016-02-19 | $823.20M 10-K · filed 2016-02-19 |
| 2013-09-30 | $151.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $281.20M derived: sum of 2 quarters · filed 2014-10-31 | $373.90M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | $129.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $222.00M 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $92.70M 10-Q · filed 2014-05-02 | |||
| 2012-12-31 | $592.60M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |